Top Medical News from Across Medscape

  • House Advances Broad Opioid Package; Senate Vote NextAlthough there was strong bipartisan support for the opioid package, lawmakers including a Texas physician already are looking for additional ways to combat abuse of drugs such as fentanyl.
  • FDA Approves Cemiplimab, First Drug for Advanced CSCCThe US Food and Drug Administration today approved cemiplimab for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced, unresectable CSCC.

Special Report

Business of Medicine

  • What Could the Midterm Elections Mean for Physicians? The November 6 midterms could support the Trump administration's healthcare policy or further the government's gridlock. Experts weigh in on the election's potential effects.
  • 'The Most Progressive Health System on the Planet'   Geisinger Health System has made headlines for offering free genetic screenings and money-back guarantees to its patients. CEO David Feinberg tells Eric Topol how it all works.

Medscape Editor-in-Chief

  • Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute, La Jolla, California